Frailty as a risk marker of adverse lower urinary symptom outcomes in patients with benign prostatic hyperplasia undergoing transurethral resection of prostate
单位:[1]Department of Urology,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan,China.外科学系华中科技大学同济医学院附属同济医院泌尿外科[2]Department of Urology, Wuhan Hospital of Traditional Chinese and Western Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.[3]Department of Urology, Wuhan No. 1 Hospital, Wuhan, China.
This study was supported by the grants from the National Natural
Science Foundation of China (NSFC #82070715), the Fundamental
Research Funds for the Central Universities (#YCJJ202201017), and
the Natural Science Foundation of Hubei Province (#2021CFB419)
第一作者单位:[1]Department of Urology,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan,China.
通讯作者:
推荐引用方式(GB/T 7714):
Ren Xiang,Wang Jing,Wang Zhixian,et al.Frailty as a risk marker of adverse lower urinary symptom outcomes in patients with benign prostatic hyperplasia undergoing transurethral resection of prostate[J].FRONTIERS IN MEDICINE.2023,10:doi:10.3389/fmed.2023.1185539.
APA:
Ren Xiang,Wang Jing,Wang Zhixian,Yin Yisheng,Li Xing...&Zeng Xiaoyong.(2023).Frailty as a risk marker of adverse lower urinary symptom outcomes in patients with benign prostatic hyperplasia undergoing transurethral resection of prostate.FRONTIERS IN MEDICINE,10,
MLA:
Ren Xiang,et al."Frailty as a risk marker of adverse lower urinary symptom outcomes in patients with benign prostatic hyperplasia undergoing transurethral resection of prostate".FRONTIERS IN MEDICINE 10.(2023)